106P Efficacy and safety of IBI351 (GFH925) monotherapy in metastatic colorectal cancer harboring KRASG12C mutation: Updated results from a pooled analysis of two phase I studies

Yanggang Yuan, Yizhou Deng, Y. Jin, Yueyin Pan, John Wang, Zhou Wang, Zijian Zhang, X. Meng, Yujie Hu, Mingming Zhao, Hui Wang, Ning Yang, Deyan Wu, Xiao-Fei Dong, Dandan Huang, Mingyu Sun, Li Liu, D. Hua, Zengqing Guo, Kaiyang Ding